Intraperitoneal Administration of 17-DMAG as an Effective Treatment against Leishmania braziliensis Infection in BALB/c Mice: A Preclinical Study
Authors:
- Kercia P. CruzKercia P. Cruz
- Antonio L. O. A. PetersenAPAntonio L. O. A. Petersen
- Marina F. AmorimMAMarina F. Amorim
- Alan G. S. F. PinhoAPAlan G. S. F. Pinho
- Luana C. PalmaLPLuana C. Palma
- Diana A. S. DantasDDDiana A. S. Dantas
- Mariana R. G. SilveiraMSMariana R. G. Silveira
- Carine S. A. SilvaCSCarine S. A. Silva
- Ana Luiza J. CordeiroACAna Luiza J. Cordeiro
- Izabella G. OliveiraIOIzabella G. Oliveira
- Gabriella B. PitaGPGabriella B. Pita
- Bianca C. A. SouzaBSBianca C. A. Souza
Open Access
Abstract
Background: Leishmaniasis is a significant global public health issue that is caused by parasites from Leishmania genus. With limited treatment options and rising drug resistance, there is a pressing need for new therapeutic approaches. Molecular chaperones, particularly Hsp90, play a crucial role in parasite biology and are emerging as promising targets for drug development. Objective: This study evaluates the efficacy of 17-DMAG in treating BALB/c mice from cutaneous leishmaniasis through in vitro and in vivo approaches. Materials and Methods: We assessed 17-DMAG’s cytotoxic effect on bone marrow-derived macrophages (BMMΦ) and its effects against L. braziliensis promastigotes and intracellular amastigotes. Additionally, we tested the compound’s efficacy in BALB/c mice infected with L. braziliensis via intraperitoneal administration to evaluate the reduction in lesion size and the decrease in parasite load in the ears and lymph nodes of infected animals. Results: 17-DMAG showed selective toxicity [selective index = 432) towards Leishmania amastigotes, causing minimal damage to host cells. The treatment significantly reduced lesion sizes in mice and resulted in parasite clearance from ears and lymph nodes. It also diminished inflammatory responses and reduced the release of pro-inflammatory cytokines (IL-6, IFN-γ, TNF) and the regulatory cytokine IL-10, underscoring its dual leishmanicidal and anti-inflammatory properties. Conclusions: Our findings confirm the potential of 17-DMAG as a viable treatment for cutaneous leishmaniasis and support further research into its mechanisms and potential applications against other infectious diseases.Keywords
All Related Versions
Funding Information
- National Council for Scientific Research and Development (CNPq) (CNPq 305235/2019-2, CNPq 309901/2023-5, FAPESB/PPSUS 5186, 46700287000, INCT-DT-465229/2014-0)
- Fundação de Amparo à Pesquisa do Estado da Bahia (CNPq 305235/2019-2, CNPq 309901/2023-5, FAPESB/PPSUS 5186, 46700287000, INCT-DT-465229/2014-0)
- Fundação Oswaldo Cruz (CNPq 305235/2019-2, CNPq 309901/2023-5, FAPESB/PPSUS 5186, 46700287000, INCT-DT-465229/2014-0)
- National Institute of Science and Technology in Tropical Diseases (CNPq 305235/2019-2, CNPq 309901/2023-5, FAPESB/PPSUS 5186, 46700287000, INCT-DT-465229/2014-0)
- CAPES (CNPq 305235/2019-2, CNPq 309901/2023-5, FAPESB/PPSUS 5186, 46700287000, INCT-DT-465229/2014-0)
- PDJ Inova Fiocruz (CNPq 305235/2019-2, CNPq 309901/2023-5, FAPESB/PPSUS 5186, 46700287000, INCT-DT-465229/2014-0)
- Fiotec—Fiocruz (CNPq 305235/2019-2, CNPq 309901/2023-5, FAPESB/PPSUS 5186, 46700287000, INCT-DT-465229/2014-0)
This publication has 30 references indexed in Scilit:
- Selective targeting of Plasmodium falciparum Hsp90 disrupts the 26S proteasomeCell Chemical Biology, 2024
- 17-DMAG inhibits the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in miceInternational Journal for Parasitology: Drugs and Drug Resistance, 2018
- Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studiesCell Stress and Chaperones, 2016
- Exploring in vitro and in vivo Hsp90 inhibitors activity against human protozoan parasitesBioorganic & Medicinal Chemistry Letters, 2015
- HSP90 as a platform for the assembly of more effective cancer chemotherapyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Heat shock protein 90 from neglected protozoan parasitesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- HSP90 inhibition by 17-DMAG reduces inflammation in J774 macrophages through suppression of Akt and nuclear factor-κB pathwaysInflammation Research, 2012
- Development and application of Hsp90 inhibitorsDrug Discovery Today, 2008
- Leishmania (Viannia) braziliensis metacyclic promastigotes purified using Bauhinia purpurea lectin are complement resistant and highly infective for macrophages in vitro and hamsters in vivoInternational Journal for Parasitology, 2002
- Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD 2 F 1 mice and Fischer 344 ratsCancer Chemotherapy and Pharmacology, 2002